Abstract:Purpose: The efficacy of traditional therapies for oral carcinoma (OC) is limited. Oncolytic adenovirus, a novel strategy of cancer therapy, shows potential use in OC treatment. However, its clinical application is limited by pre-existing neutralizing antibodies. Thus, this study aimed to examine the efficacy of a new modified adenovirus against OC in vitro and in vivo. Materials and methods: A multiple modified adenovirus (MMAD) armed with IL-13 (MMAD-IL-13) was constructed, and its effect on Cal-27 cells was examined. The potency of MMAD-IL-13 was examined in vitro and in vivo. For in vitro experiment, CCK-8 kit was used to determine the IC50 of MMAD-IL-3 in OC cell lines. For in vivo experiment, Cal-27 xenograft models were used to determine the antitumor effect of MMAD-IL-13. Apoptosis was measured in Cal-27 cells by Western blotting assay. Immunity response was detected in Cal-27 xenograft models 7 days after intratumoral injection with MMAD-IL-13. The potency of MMAD and MMAD-IL-13 was compared in Cal-27 peripheral blood mononuclear cells (PBMCs) models. Results: MMAD-IL-13 was successfully constructed; the harvested virus could be replicated and they overexpressed human IL-13 in Cal-27 cells. Compared with MMAD, MMAD-IL-13 showed enhanced antitumor effect in vitro by inducing apoptosis and reducing percentage of M2 macrophages in tumor environment in vivo. MMAD-IL-13 also showed potent antitumor effect in Cal-27, SCC-4, and Tca8113 cells in vitro and in Cal-27 xenograft models in vivo. However, MMAD-IL13 did not harm normal human oral epithelial cells in vitro and exhibited no effect on body weight in Cal-27 xenograft models. In Cal-27 PBMC models, MMAD-IL-13 showed stronger antitumor effect than MMAD. Conclusion: A new oncolytic adenovirus carrying the human IL-13 gene was constructed. This virus effectively led to remission of tumor development and death of OC cells in vivo and in vitro, showing its potential as a clinical cancer therapy.

Adenovirus-mediated overexpression of interleukin-21 regulates the development of oral squamous cell carcinoma in vitro

Interleukin-18 expression in oral squamous cell carcinoma: its role in tumor cell migration and invasion, and growth of tumor cell xenografts.

Extracellular interleukin-17F has a protective effect in oral tongue squamous cell carcinoma

Efficacy of a new oncolytic adenovirus armed with IL-13 against oral carcinoma models

Effects of Interleukin-6 on STAT3-regulated signaling in oral cancer and as a prognosticator of patient survival

Overexpression of Interleukin-18 Protein Reduces Viability and Induces Apoptosis of Tongue Squamous Cell Carcinoma Cells by Activation of Glycogen Synthase Kinase-3Β Signaling.

Potential pro‐tumour cytokine in oral squamous cellular carcinoma: IL37

The In Vitro And In Vivo Antitumor Activity Of Adenovirus-Mediated Interleukin-24 Expression For Laryngocarcinoma

Preliminary Study on Mouse Interleukin-21 Application in Tumor Gene Therapy.

Interleukin 21 treatment in a murine model as a novel potential cytokine immunotherapy for colon cancer

Serum IL-17F Combined with VEGF As Potential Diagnostic Biomarkers for Oral Squamous Cell Carcinoma

IL‐1β Promotes Malignant Transformation and Tumor Aggressiveness in Oral Cancer

Expression of Interleukin-18 in Oral Squamous Cell Carcinoma

Ccl21/Il21-Armed Oncolytic Adenovirus Enhances Antitumor Activity Against Tert-Positive Tumor Cells

Interleukin-6 mediated inflammasome activation promotes oral squamous cell carcinoma progression via JAK2/STAT3/Sox4/NLRP3 signaling pathway

Antitumor Efficacy Induced By Human Ovarian Cancer Cells Secreting Il-21 Alone Or Combination With Gm-Csf Cytokines In Nude Mice Model

Next-generation Sequencing for Microrna Profiling: MicroRNA-21-3p Promotes Oral Cancer Metastasis.

Regulation of Microrna-21 ASO on Proliferation and Apoptosis of TSCC Cell Lines

IL-21 Stimulates the expression and activation of cell cycle regulators and promotes cell proliferation in EBV-positive diffuse large B cell lymphoma

MiR-4513 Mediates the Proliferation and Apoptosis of Oral Squamous Cell Carcinoma Cells Via Targeting CXCL17

Enhanced antitumor immunity is elicited by adenovirus-mediated gene transfer of CCL21 and IL-15 in murine colon carcinomas